CKD Stages
Dialyzable substances
Salicylates
Lithium
Isopropyl Alcohol
Magnesium Laxatives
Ethylene Glycol
For proteinuric CKD patients, first line therapy includes
ACE/ARBs
MRAs if proteinuria persists
Check crt 7-14 days after starting these. If rise in > 30% – may need dose reduction.
Complications in CKD
Vasular/HTN/CHF/Afib
valvular stenosis
pericarditis
Osteitis fibrosa cystica
Anemia
Coagulopathy
Hypothyroidism
Anemia in CKD becomes clinically significant in stages
3b-4
Testing for anemia in CKD is making sure that the bone marrow can respond so test for
B12, thyroid function tests, reticulocyte count, iron stores
CKD is associated with high hepcidin
Iron suppllimentation in CKD if ferritin is below 500 mg/ml and iron sat is less than
30%
Possible side effects from starting epo stimulating agent
HTN,
acceleration of underlying malignancy
Showing progression of CKD
treat underlying cause
blood pressure control
antiproteinuric agent (ACE/ARB/MRA/SGLT2/GLP1)
Drugs that should be adjusted for GFR
Insulin/ Sulfonyureas
Metformin
Morphine metabolites
NSAIDs
PPIs